Literature DB >> 12452838

Transcriptional regulation of the IL-5 gene in peripheral T cells of asthmatic patients.

K Ogawa1, O Kaminuma, H Okudaira, H Kikkawa, K Ikezawa, N Sakurai, A Mori.   

Abstract

Mechanisms that underlie the regulation of IL-5 gene expression in human peripheral T cells remain incompletely defined because of the low efficiency of transfection of plasmid constructs into non-transformed T cells. To elucidate the cellular and molecular mechanisms of IL-5 production, concanavalin A (ConA)-stimulated blastocytes derived from peripheral blood lymphocytes of asthmatic patients were employed in this study. Transcriptional activity of the synthetic human IL-5 promoter in ConA-stimulated blastocytes correlated with the production of IL-5. Deletion analysis of the reporter gene showed that the cis-regulatory element located at - 119 to - 80 is critical for inducible IL-5 promoter activity. Electrophoretic mobility shift assay revealed that an oligonucleotide probe corresponding to the element (- 119 to - 90) gave two specific bands. The slower migrating band was absolutely dependent on stimulation and was composed of a co-operative complex of the transcription factors, nuclear factor of activated T cells (NFAT) and activating protein-1 (AP-1). The faster migrating band was also inducible and was identified as AP-1-less NFAT. Mutation of either the NFAT or AP-1 element abrogated the slower migrating band and at the same time abolished transcriptional activity of the human IL-5 promoter/enhancer gene. Cyclosporin A equivalently suppressed DNA-binding activity of the composite NFAT/AP-1 site, promoter activity and protein production of IL-5. In conclusion, these data suggests that the composite NFAT/AP-1 binding element (- 115 to - 100) plays a crucial role in IL-5 synthesis by peripheral T cells of asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452838      PMCID: PMC1906553          DOI: 10.1046/j.1365-2249.2002.01994.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters.

Authors:  T J Novak; F K Yoshimura; E V Rothenberg
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis.

Authors:  A Mori; O Kaminuma; K Miyazawa; K Ogawa; H Okudaira; K Akiyama
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

3.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage.

Authors:  C Walker; E Bode; L Boer; T T Hansel; K Blaser; J C Virchow
Journal:  Am Rev Respir Dis       Date:  1992-07

4.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

Authors:  Q Hamid; M Azzawi; S Ying; R Moqbel; A J Wardlaw; C J Corrigan; B Bradley; S R Durham; J V Collins; P K Jeffery
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Nuclear factor of activated T cells contains Fos and Jun.

Authors:  J Jain; P G McCaffrey; V E Valge-Archer; A Rao
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

Review 6.  The mechanism of action of cyclosporin A and FK506.

Authors:  S L Schreiber; G R Crabtree
Journal:  Immunol Today       Date:  1992-04

7.  CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea.

Authors:  H Nakajima; I Iwamoto; S Tomoe; R Matsumura; H Tomioka; K Takatsu; S Yoshida
Journal:  Am Rev Respir Dis       Date:  1992-08

Review 8.  T cells and eosinophils in the pathogenesis of asthma.

Authors:  C J Corrigan; A B Kay
Journal:  Immunol Today       Date:  1992-12

9.  A model of human cytokine regulation based on transfection of gamma interferon gene fragments directly into isolated peripheral blood T lymphocytes.

Authors:  J C Chrivia; T Wedrychowicz; H A Young; K J Hardy
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

10.  Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.

Authors:  A B Kay; S Ying; V Varney; M Gaga; S R Durham; R Moqbel; A J Wardlaw; Q Hamid
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  6 in total

1.  Role of activator protein-1 in the transcription of interleukin-5 gene regulated by protein kinase C signal in asthmatic human T lymphocytes.

Authors:  Qi Guo; Yongjian Xu; Zhenxiang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation.

Authors:  Hyeonju Yeo; Lauren H Beck; Jay M McDonald; Majd Zayzafoon
Journal:  Bone       Date:  2007-02-24       Impact factor: 4.398

3.  TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis.

Authors:  Eun-Jin Bae; Minsun Choi; Jeong Tae Kim; Dong-Kyu Kim; Min Kyo Jung; Changyoun Kim; Tae-Kyung Kim; Jun Sung Lee; Byung Chul Jung; Soo Jean Shin; Ka Hyun Rhee; Seung-Jae Lee
Journal:  Exp Mol Med       Date:  2022-07-05       Impact factor: 12.153

4.  New drugs targeting Th2 lymphocytes in asthma.

Authors:  Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

Review 5.  Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology.

Authors:  Anatoliy Gladkevich; S Adriaan Nelemans; Henk F Kauffman; Jakob Korf
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

6.  ASIC1a induces synovial inflammation via the Ca2+/NFATc3/ RANTES pathway.

Authors:  Yihao Zhang; Xuewen Qian; Xiaojuan Yang; Ruowen Niu; Sujing Song; Fei Zhu; Chuanjun Zhu; Xiaoqing Peng; Feihu Chen
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.